Month: March 2015

NEW FRAMEWORK MEASURES FAIRNESS WHEN DISTRIBUTING VACCINES

Blacksburg, VA, USA – When vaccines are in short supply, public health officials must decide who among the public should be protected against disease – a decision that can hold moral and ethical implications. In order to avoid such concerns,

Posted in Announcements, Health Policy Analyses Tagged with: , , , , , ,

INDUSTRY AND GOVERNMENT LEADERS OUTLINE POTENTIAL FOR SOCIAL MEDIA TO ACCELERATE PRO DEVELOPMENT

Raritan, NJ, USA – A collaboration designed to open dialogue between industry and government leaders has found “great potential” for social media to support content validity of patient-reported outcomes (PRO) instruments, and outlined how the use of social media can

Posted in Commentary, Value in Health Tagged with: , , , , , ,

ANTICIPATING TREATMENT NON-PERSISTENCE THROUGH AN INNOVATIVE CONCEPTUAL FRAMEWORK

Paderborn, Germany – Using principles from behavioral economics to model patient decisions, innovative research published in Value in Health proposes a framework to understand the reasons for treatment non-persistence and predicts the point at which a patient will stop taking

Posted in Preference-Based Assessments, Value in Health Tagged with: , ,

ISPOR BOARD OF DIRECTORS ELECTION 2015

Dear Colleagues: The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a member-driven organization led by a diverse Board of Directors and professional staff who work collaboratively to ensure the organization is strategically positioned and effectively serving its membership.

Posted in Announcements